These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29788391)

  • 21. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
    Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
    Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAS status in Korean patients with stage III and IV colorectal cancer.
    Lee WS; Lee JN; Baek JH; Park YH
    Clin Transl Oncol; 2015 Sep; 17(9):751-6. PubMed ID: 25997687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.
    Koochak A; Rakhshani N; Karbalaie Niya MH; Tameshkel FS; Sohrabi MR; Babaee MR; Rezvani H; Bahar B; Imanzade F; Zamani F; Khonsari MR; Ajdarkosh H; Hemmasi G
    Asian Pac J Cancer Prev; 2016; 17(2):603-8. PubMed ID: 26925650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.
    Liddell C; Droy-Dupré L; Métairie S; Airaud F; Volteau C; Bezieau S; Laboisse CL; Mosnier JF
    Mod Pathol; 2017 Aug; 30(8):1177-1189. PubMed ID: 28429715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.
    Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Zhu B; Nikiforova M; Bartlett DL; Pai RK
    Mod Pathol; 2014 Nov; 27(11):1521-39. PubMed ID: 24633196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
    Tajiri K; Sudou T; Fujita F; Hisaka T; Kinugasa T; Akagi Y
    Anticancer Res; 2017 Jul; 37(7):3817-3823. PubMed ID: 28668881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
    Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
    Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
    Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
    Anglesio MS; Kommoss S; Tolcher MC; Clarke B; Galletta L; Porter H; Damaraju S; Fereday S; Winterhoff BJ; Kalloger SE; Senz J; Yang W; Steed H; Allo G; Ferguson S; Shaw P; Teoman A; Garcia JJ; Schoolmeester JK; Bakkum-Gamez J; Tinker AV; Bowtell DD; Huntsman DG; Gilks CB; McAlpine JN
    J Pathol; 2013 Jan; 229(1):111-20. PubMed ID: 22899400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
    Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
    Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia.
    Harpaz N; Taboada S; Ko HM; Yu J; Yang Q; Xu H; Cao W
    Inflamm Bowel Dis; 2014 Apr; 20(4):703-11. PubMed ID: 24518605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of signet-ring cells in patients with colorectal cancer.
    Pande R; Sunga A; Levea C; Wilding GE; Bshara W; Reid M; Fakih MG
    Dis Colon Rectum; 2008 Jan; 51(1):50-5. PubMed ID: 18030531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations.
    Sasaki S; Masaki T; Umetani N; Futakawa N; Ando H; Muto T
    Jpn J Clin Oncol; 1998 Mar; 28(3):202-6. PubMed ID: 9614444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.
    Secco GB; Fardelli R; Campora E; Lapertosa G; Gentile R; Zoli S; Prior C
    Oncology; 1994; 51(1):30-4. PubMed ID: 8265100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
    Hartman DJ; Nikiforova MN; Chang DT; Chu E; Bahary N; Brand RE; Zureikat AH; Zeh HJ; Choudry H; Pai RK
    Am J Surg Pathol; 2013 Jul; 37(7):969-77. PubMed ID: 23681075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
    Hyngstrom JR; Hu CY; Xing Y; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA; Cormier JN; Chang GJ
    Ann Surg Oncol; 2012 Sep; 19(9):2814-21. PubMed ID: 22476818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.